NEU 2.50% $15.59 neuren pharmaceuticals limited

Ann: New patent issued to 2032 for Neuren's trofinetide in Canada, page-15

  1. 5,937 Posts.
    lightbulb Created with Sketch. 18203
    Two new patent applications have been published.

    The first is Publication No: WO/2021/086892 - METHODS AND COMPOSITIONS FOR TREATMENT OF RETT SYNDROME, and is a joint application between Acadia and Neuren. It makes claim for methods of treating Rett syndrome comprising administering trofinetide to a subject in need thereof in which a dosage is provided that may reduce or avoid underexposure, e.g., in low body weight subjects, and/or provide other benefits. The filing date is 28 October 2020.

    https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2021086892&_cid=P21-KODUET-62289-1


    The second is Publication NO: WO2021080646 - BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME. Named inventors are Cogram, Pilcher and Glass. It was filed on 24 April, 2020.

    https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2021080646&_cid=P21-KODUET-62289-1
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.